SAC's Cohen States `Appropriate Action' on Trades

Nov. 28 (Bloomberg) -- Bloomberg's Su Keenan reports that on a conference call that acknowledged the firm receiving a Wells Notice from the SEC, SAC Capital Advisors CEO Steven Cohen stated that he acted appropriately while trading shares of drug makers in 2008. She speaks on Bloomberg Television's "Money Moves."

Celgene’s Hugin: We Should Charge a Fair Price
20:19 - Celgene Executive Chairman Bob Hugin discusses President Trump’s comments on drug prices, reform in the pharma industry, prospects for growth and Obamacare. He speaks on “Bloomberg Markets.” (Source: Bloomberg)
  • Spicer: Trump Has Healthy Respect for First Amendment
  • White House Spokesman Spicer: Intention Is Never to Lie
  • Spicer: Trade Pacts Like TPP Not in U.S. Best Interest